Skip to content
Review

Lifelong Epstein-Barr virus persistence as a stress test of ageing immune surveillance: from infectious mononucleosis to chronic active EBV disease and virus-associated malignancy.

Sep 2026 · Ageing Research Reviews · pp. 103387 · 0 citations · 157 references
Medicine

Abstract

Epstein-Barr virus (EBV) infects most humans and persists lifelong within a dynamic equilibrium maintained by B-cell latency, cytotoxic T-cell control, NK-cell surveillance and humoral immunity. Ageing can remodel this equilibrium through thymic involution, contraction of the naive T-cell pool, accumulation of late-differentiated or exhaustion-like T-cell states, altered NK-cell function, B-cell dysfunction and chronic low-grade inflammation. Although cytomegalovirus has dominated discussions of persistent viral infection and immunosenescence, EBV offers a complementary model because it combines lifelong latency, intermittent reactivation, B-cell tropism, immune evasion and clinically diverse lymphoid, epithelial and hyperinflammatory disease contexts. This review conceptualizes EBV persistence as a functional stress test of ageing immune surveillance. Instead of assigning EBV a binary role as either a driver or passenger of immunosenescence, we argue that EBV may reveal and amplify deficits in viral containment, tissue immune ecology and inflammatory regulation. We integrate evidence from EBV-specific immune control, T-cell and NK-cell ageing, B-cell remodelling, inflammaging and EBV-associated diseases including IM, CAEBV, ENKTL, EBV-HLH, EBVMCU, EBV-positive DLBCL, PTLD, NPC and EBV-associated gastric cancer. These entities are organized as parallel immune-control states rather than as a chronological disease sequence: CAEBV and ENKTL illustrate T/NK-lineage containment failure, EBV-HLH links impaired cytotoxic reserve with inflammatory escalation, B-cell lymphoproliferative diseases illustrate surveillance loss, and epithelial cancers illustrate tissue-specific latency and local immune editing. A lifespan perspective on EBV may therefore clarify why some immune systems maintain resilient latency, whereas others lose EBV-control reserve and become permissive to reactivation, hyperinflammation, lymphoproliferation or malignancy.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.